将ITIM受体G6b-B与酪氨酸磷酸酶Shp1和Shp2解偶联破坏小鼠血小板稳态
本研究通过构建ITIM和ITSM中酪氨酸残基212和238突变为苯丙氨酸的G6b-B diY/F转基因小鼠,发现该小鼠表现为大血小板减少症、巨核细胞簇和骨髓纤维化,血小板对胶原和凝血酶低反应,但对CLEC-2交联高反应,表明G6b-B需与Shp1和Shp2结合才能调控血小板稳态。
要点
- G6b-B diY/F小鼠出现大血小板减少症,由血小板生成减少所致。
- G6b-B diY/F小鼠血小板对胶原和凝血酶低反应,对CLEC-2交联高反应。
- G6b-B需与Shp1和Shp2结合以调控血小板稳态。
核心结论
- G6b-B必须与Shp1和Shp2结合才能介导其对血小板稳态的调控作用。
研究设计与样本
- 本研究构建了表达ITIM和ITSM中酪氨酸残基212和238突变为苯丙氨酸的G6b-B突变体的转基因小鼠模型(G6b-B diY/F)。
主要发现
- G6b-B diY/F纯合子小鼠表现为大血小板减少症,由血小板生成减少所致,并在造血部位出现巨核细胞大簇和骨髓纤维化,与G6b缺陷小鼠和患者中观察到的相似。
- G6b-B diY/F小鼠血小板对胶原低反应,由含ITAM的胶原受体复合物GPVI-FcR γ链表达显著降低所致,对凝血酶也低反应,用二磷酸腺苷共刺激可部分挽救。
- G6b-B diY/F、G6b KO和巨核细胞特异性Shp2 KO小鼠的血小板对抗体介导的含半ITAM的podoplanin受体CLEC-2交联高反应,提示G6b-B通过Shp2抑制CLEC-2介导的血小板活化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing receptor G6b-B has emerged as a key regulator of platelet homeostasis. However, it remains unclear how it mediates its effects. Tyrosine phosphorylation of ITIM and immunoreceptor tyrosine-based switch motif (ITSM) within the cytoplasmic tail of G6b-B provides a docking site for Src homology 2 domain-containing protein-tyrosine phosphatases Shp1 and Shp2, which are also critical regulators of platelet production and function. In this study, we investigate the physiological consequences of uncoupling G6b-B from Shp1 and Shp2. To address this, we generated a transgenic mouse model expressing a mutant form of G6b-B in which tyrosine residues 212 and 238 within ITIM and ITSM were mutated to phenylalanine. Mice homozygous for the mutation (G6b-B diY/F) were macrothrombocytopenic, as a result of the reduction in platelet production, and had large clusters of megakaryocytes and myelofibrosis at sites of hematopoiesis, similar to those observed in G6b-deficient mice and patients. Platelets from G6b-B diY/F mice were hyporesponsive to collagen, as a result of the significant reduction in the expression of the immunoreceptor tyrosine-based activation motif (ITAM)-containing collagen receptor complex GPVI-FcR γ-chain, as well as thrombin, which could be partially rescued by costimulating the platelets with adenosine diphosphate. In contrast, platelets from G6b-B diY/F, G6b KO, and megakaryocyte-specific Shp2 KO mice were hyperresponsive to antibody-mediated cross-linking of the hemi-ITAM-containing podoplanin receptor CLEC-2, suggesting that G6b-B inhibits CLEC-2-mediated platelet activation through Shp2. Findings from this study demonstrate that G6b-B must engage with Shp1 and Shp2 to mediate its regulatory effects on platelet homeostasis.
引用
- Geer MJ, van Geffen JP, Gopalasingam P, et al. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis. Blood. 2018. PMID: 29891536. doi:10.1182/blood-2017-10-802975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。